JD Supra

The US and UK Reach Agreement in Principle on Pharmaceuticals, Pharmaceutical Ingredients, and Medical Technology

On December 1, 2025, the United States and United Kingdom announced an agreement in principal on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under the agreement, the U.S. will ...
Morningstar

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA / ACCESS Newswire / January 12, 2026 / Amphastar Pharmaceuticals, ...
Nasdaq

Rani Therapeutics Enters Research Agreement with Chugai Pharmaceutical to Explore Oral Delivery Technology for Antibody Development

Rani Therapeutics Holdings, Inc. has announced a research agreement with Chugai Pharmaceutical Co., Ltd. to evaluate the potential of Rani’s oral delivery technology, specifically the RaniPill®, for ...
Nasdaq

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

RANCHO CUCAMONGA, CA / ACCESS Newswire / January 12, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that it has entered into an exclusive license agreement (the "Agreement") with ...